MARKET

HROW

HROW

Harrow Health Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.94
+0.05
+0.85%
Closed 16:00 09/16 EDT
OPEN
5.90
PREV CLOSE
5.89
HIGH
6.03
LOW
5.82
VOLUME
191.51K
TURNOVER
--
52 WEEK HIGH
8.99
52 WEEK LOW
2.220
MARKET CAP
149.49M
P/E (TTM)
7.48
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HROW and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HROW News

  • Week 37 Breakout Forecast: Short-Term Picks To Give You An Edge
  • Seeking Alpha - Article.09/07 16:18
  • Harrow Health 8-K Shows Centers For Medicare & Medicaid Services Issued Update On Hospital Outpatient Prospective Systems, Effective Oct. 1, 2019
  • Benzinga.09/05 11:44
  • Harrow Health to Attend Lake Street’s 3rd Annual Best Ideas Growth Conference September 12, 2019
  • GlobeNewswire.08/27 11:30
  • Harrow Health Enters Oversold Territory
  • Zacks.08/19 10:24

More

Industry

Biotechnology & Medical Research
+1.06%
Pharmaceuticals & Medical Research
-0.13%

Hot Stocks

Name
Price
%Change

About HROW

Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., owns diversified portfolio of healthcare businesses. The Company’s subsidiaries are Imprimis Pharmaceuticals Inc. and Park Compounding. Imprimis Pharmaceuticals Inc. is engaged in ophthalmology pharmaceutical compounding business. Park Compounding is engaged in compounding business and also offers strategic research and development facilities, which is engaged in developing and dispensing medicines for individual patients.
More

Webull offers Harrow Health Inc (HROW) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.